Iovance Biotherapeutics News - IOVA

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Iovance Biotherapeutics Inc IOVA NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.18 0.62% 29.06 27.50 29.25 28.68 28.88 00:00:07
more quote information »

Recent News

Date Time Source Heading
4/03/202016:31EDGARStatement of Changes in Beneficial Ownership (4)
3/04/202017:01EDGARStatement of Changes in Beneficial Ownership (4)
3/02/202016:01GLOBEIovance Biotherapeutics to Present at Upcoming Conferences
2/25/202017:14EDGARAnnual Report (10-k)
2/25/202016:11EDGARCurrent Report Filing (8-k)
2/25/202016:01GLOBEIovance Biotherapeutics Reports Fourth Quarter and Full-Year..
2/24/202016:18EDGARAmended Statement of Ownership (sc 13g/a)
2/19/202007:00GLOBEIovance Biotherapeutics to Host Fourth Quarter and Full Year..
2/14/202016:03EDGARAmended Statement of Ownership (sc 13g/a)
2/14/202013:44EDGARStatement of Ownership (sc 13g)
2/14/202010:04EDGARAmended Statement of Ownership (sc 13g/a)
2/12/202007:00GLOBEIovance Biotherapeutics to Present at Upcoming Healthcare..
2/11/202016:42EDGARStatement of Ownership (sc 13g)
2/05/202016:32EDGARStatement of Changes in Beneficial Ownership (4)
2/05/202011:49EDGARAmended Statement of Ownership (sc 13g/a)
2/04/202016:56EDGARAmended Statement of Ownership (sc 13g/a)
1/15/202008:00GLOBEIovance Biotherapeutics Completes Patient Dosing in..
1/13/202013:12DJNIovance Shares Down 10% After Licensing Drug From Novartis
1/12/202016:30GLOBEIovance Biotherapeutics Obtains License to Develop and..
1/12/202016:00GLOBEIovance Biotherapeutics and Cellectis Enter into a Research..
12/02/201907:00GLOBEIovance Biotherapeutics to Present at Upcoming Investor..
11/21/201907:00GLOBEIovance Biotherapeutics Announces Results of a Subgroup..
11/08/201913:20EDGARConfidential Treatment Order (ct Order)
11/08/201907:00GLOBEIovance Biotherapeutics Announces Updated Phase 2 Clinical..
11/07/201916:32GLOBEIovance Biotherapeutics to Present at Upcoming Investor..
11/04/201917:03EDGARQuarterly Report (10-q)
11/04/201916:13EDGARCurrent Report Filing (8-k)
11/04/201916:01GLOBEIovance Biotherapeutics Reports Third Quarter and September..
10/31/201916:43GLOBEIovance Biotherapeutics to Host Third Quarter 2019 Financial..
10/02/201907:00GLOBEIovance Biotherapeutics Announces Four Abstracts to be..
9/27/201916:30GLOBEIovance Biotherapeutics to Present at Upcoming Conferences
9/25/201906:00EDGARNotice of Effectiveness (effect)
9/17/201916:12EDGARSecurities Registration Statement (simplified Form) (s-3/a)
8/30/201917:03EDGARSecurities Registration Statement (simplified Form) (s-3)
8/26/201916:30GLOBEIovance Biotherapeutics to Present at Upcoming Investor..
8/01/201917:03EDGARQuarterly Report (10-q)
8/01/201916:07EDGARCurrent Report Filing (8-k)
8/01/201916:01GLOBEIovance Biotherapeutics Reports Second Quarter 2019..
7/26/201907:00GLOBEIovance Biotherapeutics to Host Second Quarter 2019..
7/19/201917:17EDGARStatement of Changes in Beneficial Ownership (4)
7/19/201917:15EDGARInitial Statement of Beneficial Ownership (3)
7/18/201908:00GLOBEIovance Biotherapeutics Appoints Friedrich Graf..
7/02/201908:01EDGARCurrent Report Filing (8-k)
7/02/201907:30GLOBEIovance Biotherapeutics Provides Cervical Cancer Program..
6/21/201916:46EDGARCurrent Report Filing (8-k)
6/11/201917:17EDGARStatement of Changes in Beneficial Ownership (4)
6/11/201917:17EDGARStatement of Changes in Beneficial Ownership (4)
6/11/201917:17EDGARStatement of Changes in Beneficial Ownership (4)
6/11/201917:16EDGARInitial Statement of Beneficial Ownership (3)
6/11/201908:00EDGARCurrent Report Filing (8-k)
See more news about this stock »


Your Recent History
NASDAQ
IOVA
Iovance Bi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.